Company Filing History:
Years Active: 2025
Title: Robert Langland Eil: Innovator in Cell Culture Methods
Introduction
Robert Langland Eil is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cell culture, particularly in methods that enhance the growth and engineering of various cell types. His innovative work is crucial for advancements in immunotherapy and regenerative medicine.
Latest Patents
Eil holds a patent for "Methods for culturing cells." This patent outlines techniques for culturing pluripotent, multipotent, and immune cells, such as T cells and NK cells, in a medium containing at least about 5 mM potassium ion. The methods described in the patent aim to increase the number of less-differentiated cells in the population, which is essential for various therapeutic applications. The cultured cells can also be engineered to include chimeric antigen receptors or engineered T cell receptors, making them suitable for administration to subjects in need.
Career Highlights
Robert Langland Eil is currently associated with Lyell Immunopharma, Inc., where he continues to develop innovative solutions in cell culture and immunotherapy. His work is instrumental in pushing the boundaries of what is possible in cellular therapies.
Collaborations
Eil collaborates with esteemed colleagues such as Suman Kumar Vodnala and Nicholas P Restifo. Their combined expertise contributes to the advancement of research in cell culture and immunotherapy.
Conclusion
Robert Langland Eil is a pioneering inventor whose work in cell culture methods is shaping the future of immunotherapy. His contributions are vital for the development of effective treatments in regenerative medicine.